U.S. drug development Phase III success rates from 2006 to 2015, by disease area

This statistic shows the probability of Phase III success for new drugs in the U.S., in the period from January 1, 2006 to December 31, 2015, by disease area. It was found that drugs in hematology had the highest Phase III success rates.

The probability of Phase III success for new drugs in select disease areas in the U.S. between 2006 and 2015

Phase III success rate
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

May 2016

Region

United States

Survey time period

January 1, 2006 to December 31, 2015

Supplementary notes

* Gastroenterology does not include IBD.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Clinical trials"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.